Form 4 for OPRX OptimizeRx Corp
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-13 · accession 0001213900-21-043479 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-17 | 2021-08-13+ | OPRX | BAKER DOUGLAS P | CFO | S - Sale | $61.13 | -9,000 | 63.8K | -12% | -$550.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-13 | S | D | 5,000 | $63.27 | 67,796 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on June 18, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 2 | Common | Common Stock (pursuant to 10B5-1 plan) | 2021-08-17 | S | D | 4,000 | $58.46 | 63,796 | D | — | — | (F2) These shares sold pursuant to a plan of disposition adopted on May 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |